RILTOZINAMERAN
UNII 72JR7XDV94

Substance Identification & Data

This profile provides standardized clinical and technical data for Riltozinameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 72JR7XDV94.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2749948-25-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
72JR7XDV94
CAS Registry Number
2749948-25-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RILTOZINAMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188525
National Cancer Institute reference terminology for clinical and research data.
INN ID
12510
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Riltozinameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILTOZINAMERAN

Common Names & Synonyms

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K983P AND V984P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; OMICRON VARIANT AND B.1.1.529 AND HCOV-19/BOTSWANA/R42B5_BHP_AAC25114/2021 AND GISAID: EPI_ISL_6752026) SPIKE (S) GLYCOPROTEIN, FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLY(A) TAIL AND CONTAINS N1-ETHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
RILTOZINAMERAN [INN]
RILTOZINAMERAN [WHO-DD]
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED SPIKE GLYCOPROTEIN B.1.1.529 VARIANT-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER BNT162B2_B.1.1.529), INNER SALT

Technical Codes

BNT162B2_B.1.1.529

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus